Dian Wang, William Tseng, Brian Van Tine appointed to new Sarcoma Subcommittee at NRG Oncology; Clifton Fuller named vice chair of Imaging Committee

Knight Cancer Institute receives record-setting $2B gift from the Knights—and self-governance within OHSU
Brian Druker returns to executive role as president of the new Knight Cancer Group

Phil and Penny Knight made a record-setting $2 billion gift to OHSU Knight Cancer Institute.Phil and Penny Knight with Brian Druker, right.

August 14, 2025

By Paul Goldberg and Sara Willa Ernst

In Brief

Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program

Antonio WolffMikala EgebladAntonio C. Wolff and Mikala Egeblad were named co-directors of the Breast and Gynecologic Cancer Program at Johns Hopkins Kimmel Cancer Center.

August 08, 2025

Vol.51 No.31

In Brief

Joseph Contessa appointed chair of radiation oncology at Rutgers Cancer Institute

Joseph Contessa was named chair of radiation oncology for Rutgers Cancer Institute, Rutgers Robert Wood Johnson Medical School, and Rutgers New Jersey Medical School. He will also serve as associate director for translational research at Rutgers Cancer Institute.

August 08, 2025

Vol.51 No.31

In Brief

Jaime LaMontagne named chief marketing officer of Astrin Biosciences

Jaime LaMontagne was appointed chief marketing officer of Astrin Biosciences.

August 08, 2025

Vol.51 No.31

News Analysis

Vinay Prasad falls from grace at FDA upon flunking Trump political purity test
MAHA leaders agree on one point: COVID was mishandled. Is that enough to run science-based agencies?

It’s not a good week to be Vinay Prasad.

August 01, 2025

Vol.51 No.30

By Claire Marie Porter

In Brief

Shane Jacobson named CEO of the American Cancer Society, ACS CAN

Shane Jacobson was appointed CEO of the American Cancer Society and the American Cancer Society Cancer Action Network.

July 25, 2025

Vol.51 No.29

Dian Wang, William Tseng, Brian Van Tine appointed to new Sarcoma Subcommittee at NRG Oncology; Clifton Fuller named vice chair of Imaging Committee

YOU MAY BE INTERESTED IN

Knight Cancer Institute receives record-setting $2B gift from the Knights—and self-governance within OHSU
Brian Druker returns to executive role as president of the new Knight Cancer Group

Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program

Joseph Contessa appointed chair of radiation oncology at Rutgers Cancer Institute

Jaime LaMontagne named chief marketing officer of Astrin Biosciences

Vinay Prasad falls from grace at FDA upon flunking Trump political purity test
MAHA leaders agree on one point: COVID was mishandled. Is that enough to run science-based agencies?

Shane Jacobson named CEO of the American Cancer Society, ACS CAN

Renew today!

Subscriber content

Never miss an issue!

Login

Dian Wang, William Tseng, Brian Van Tine appointed to new Sarcoma Subcommittee at NRG Oncology; Clifton Fuller named vice chair of Imaging Committee

YOU MAY BE INTERESTED IN

Knight Cancer Institute receives record-setting $2B gift from the Knights—and self-governance within OHSUBrian Druker returns to executive role as president of the new Knight Cancer Group

Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program

Joseph Contessa appointed chair of radiation oncology at Rutgers Cancer Institute

Jaime LaMontagne named chief marketing officer of Astrin Biosciences

Vinay Prasad falls from grace at FDA upon flunking Trump political purity testMAHA leaders agree on one point: COVID was mishandled. Is that enough to run science-based agencies?

Shane Jacobson named CEO of the American Cancer Society, ACS CAN

Never miss an issue!

Login

Knight Cancer Institute receives record-setting $2B gift from the Knights—and self-governance within OHSU
Brian Druker returns to executive role as president of the new Knight Cancer Group

Vinay Prasad falls from grace at FDA upon flunking Trump political purity test
MAHA leaders agree on one point: COVID was mishandled. Is that enough to run science-based agencies?